Company profile: Optimer Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of anti-infective biopharmaceutical products focused on discovering, developing and commercializing treatments for gastrointestinal infections, including late-stage candidates fidaxomicin and Pruvel (prulifloxacin).
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Optimer Pharmaceuticals
Carbogen Amcis
HQ: Switzerland
Website
- Description: Provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries, including CDMO support for drug substances and drug products, high potency API development and manufacturing, production of cholesterol, lanolin derivatives and vitamin D/D2 analogs, integrated analytical services, and non-GMP manufacturing of starting materials, intermediates, fine and specialty chemicals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carbogen Amcis company profile →
Lotus Clinical Research
HQ: United States
Website
- Description: Provider of full-service CRO services and a network of 20+ wholly-owned US clinical research sites for analgesic programs and trials in psychiatry, neurology, pain, and addiction. Services include project management, site selection and monitoring, EDC and data management, biostatistics, medical monitoring, medical writing, quality operations, placebo response mitigation, global rater training, scientific consultation, and metabolic disease trial support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lotus Clinical Research company profile →
Ology Bio
HQ: United States
Website
- Description: Provider of biologics CDMO services specializing in single-use processes and manufacturing up to BSL-3.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ology Bio company profile →
Analytical Lab Group
HQ: United States
Website
- Description: Provider of microbiology, virology, and analytical chemistry testing services for medical devices and biopharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Analytical Lab Group company profile →
Absorption Systems
HQ: United States
Website
- Description: Provider of research tools developed and implemented to help customers better predict human outcomes, serving a wide variety of pharmaceutical and biotech industry customers, including small virtual pharma companies; with locations in Exton, Pennsylvania; San Diego, California; and Panama City, Panama.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Absorption Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Optimer Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Optimer Pharmaceuticals
2.2 - Growth funds investing in similar companies to Optimer Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Optimer Pharmaceuticals
4.2 - Public trading comparable groups for Optimer Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →